<SEC-DOCUMENT>0001404644-25-000068-index.html : 20250613 <SEC-HEADER>0001404644-25-000068.hdr.sgml : 20250613 <ACCEPTANCE-DATETIME>20250613120742 ACCESSION NUMBER: 0001404644-25-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250612 FILED AS OF DATE: 20250613 DATE AS OF CHANGE: 20250613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAFFI ROBERT CENTRAL INDEX KEY: 0001274826 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 251045336 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neurogene Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 980542593 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: (877) 237-5020 MAIL ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: Neoleukin Therapeutics, Inc. DATE OF NAME CHANGE: 20190812 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>wk-form4_1749830856.xml <DESCRIPTION>FORM 4 <TEXT> Document 1 - file: wk-form4_1749830856.html
Document 1 - RAW XML: wk-form4_1749830856.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24 <SEQUENCE>2 <FILENAME>ngnesection16poa_rbaffix.htm <DESCRIPTION>EX-24 <TEXT> Document 2 - file: ngnesection16poa_rbaffix.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ngnesection16poa_rbaffix001.jpg <TEXT> Document 3 - file: ngnesection16poa_rbaffix001.jpg
</DOCUMENT> </SEC-DOCUMENT>